Copyright
©The Author(s) 2023.
World J Crit Care Med. Jun 9, 2023; 12(3): 92-115
Published online Jun 9, 2023. doi: 10.5492/wjccm.v12.i3.92
Published online Jun 9, 2023. doi: 10.5492/wjccm.v12.i3.92
Ref. | Study Design | n | Treatment arms | Sedation | Outcomes | ||
Studies comparing pressure support ventilation against assist control ventilation | |||||||
Parthasarathy et al[79], 2002 | Single centre, randomised, cross over study | 11 | 2 h each of: | ACV; Vt: 8 mL/kg; f: Set as patient RR minus 4/min | Yes | Sleep efficiency: Arousal index, mean (SD) | Not reported; ACV 39 (6); PSV 35 (7); No statistically significant difference between ventilation modes |
Toublanc et al[81], 2007 | Single centre, randomised, cross over study | 20 | 4 h each of: | ACV; Vt: 10 ml/kg; f: 12/min; Increased until no spontaneous inspiratory effort | Free from sedation for 48 h | Sleep efficiency: Arousal index, mean (SD) | No difference, values not reported; ACV 7 (SD 5); PSV 7 (SD 5); No statistically significant difference between ventilation modes |
Cabello et al[82], 2008 | Single centre, randomised, cross over study | 15 | 6 h each of: cPSV; PS to achieve Vt 6-8 ml/kg (PBW); RR < 35/min; aPSV | ACV; Vt: 8 mL/kg; f: 10/min (back up) | Free from sedation for 24 h | Sleep efficiency, median [IQR]: Arousal index, median [IQR] | ACV 58 [48-82], cPSV 44 [29-30], aPSV 63 [29-80]; ACV 30 [17-41], PSV 28 [17-53], aPSV 23 [21-45]; No statistically significant difference between ventilation modes |
Studies comparing pressure support ventilation against pressure control ventilation | |||||||
Andréjak et al[83], 2013 | Single centre, randomised,cross over study | 26 | 4 h each of: | PCV; PS = 20 cmH2O; f: Greater than patient RR I/E ratio: 1/1.2 to 1/1.5 | Not reported | Sleep efficiency, median [IQR]: Arousal index | PCV 63 [9-100]; PSV 37 [0-96] Not reported; Significantly improved sleep efficiency with PCV |
Studies comparing pressure support ventilation against proportional assist ventilation | |||||||
Bosma et al[84], 2007 | Single centre, randomised, cross over study | 13 | 1 night each of: PSV | PAV | Propofol, midazolam or lorazepam | Sleep efficiency, mean (SD): Arousal index, median [IQR]: Patient-ventilator asynchrony per hour, mean (SD) | PSV 58% (25); PAV 60 (23); PSV 16 (2-74); PAV 9 (1-41); PSV 53 (59); PAV 24 (15); PAV associated with statistically significantly fewer arousals and episodes of asynchrony |
Alexopoulou et al[85], 2007 | Single centre, randomised, cross over study | 17 | 1 night each of: | PAV+base; Set to achieve mean inspiratory pressure similar to PSVbase; PAV+high; Percentage of unloading increased by 40%-50% from PSVbase or until it reached 85% | Group A; n = 11; Propofol; Group B; n = 9; Non-sedated | Group A; Sleep efficiency, mean (SD): Arousal index, mean (SD): Group B; Sleep efficiency, mean (SD): Arousal index, mean (SD) | PAV+base 99 (2); PAVhigh 98 (5); |
Alexopoulou et al[86], 2013 | Single centre, randomised,cross over study | 14 | Alternating 4-h blocks over 24 h of: | Free from sedation and opioids for 24 h | Sleep efficiency, median [IQR]: Arousal index, median [IQR] | PAV+ 51 [13-66]; PSV 27 [6-22]; PAV+ 11 [4-25]; PSV 12 [3-16]; No statistically significant improvement found with PAV+ | |
PSV; PS maintained at pre-study level | PAV+; % of unloading set to achieve a mean inspiratory pressure similar to PSV | ||||||
Studies comparing pressure support ventilation against neurally adjusted ventilatory assist | |||||||
Delisle et al[236], 2011 | Single centre, randomised, cross over study | 14 | 2 non-consecutive 4-h blocks (d/night) of: | Free from sedation and opioids for 24 h | Sleep efficiency, median [IQR]: Fragmentation index, median [IQR] | NAVA 74 [52-77]; PSV 44 [29-74]; NAVA 18 [8-22]; PSV 34 [25-54]; NAVA statistically significant improvement in the efficiency and reduced fragmentation of sleep | |
PSV; PS to achieve Vt 8 mL/kg; RR < 35/min | NAVA |
- Citation: Showler L, Ali Abdelhamid Y, Goldin J, Deane AM. Sleep during and following critical illness: A narrative review. World J Crit Care Med 2023; 12(3): 92-115
- URL: https://www.wjgnet.com/2220-3141/full/v12/i3/92.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v12.i3.92